Intuitive: The Supplier That Could Go DirectThin moat
Synektik (SNT) — moat facet
Intuitive can replace Synektik without winning a single tender, simply by not renewing.
Synektik's most powerful competitor is the company whose products it sells. Intuitive Surgical sells directly in most of its markets and has been moving distributor territories in-house. On 1 March 2026 it bought the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for about $533,1 million and became the direct distributor for Italy, Spain, Portugal, Malta and San Marino1.
It took the opposite decision for Synektik. The annex of February 2026 extended the Polish, Czech, Slovak and Baltic agreement to 31 December 2031 and added Ukraine2. In 2022 Intuitive had gone further still, selling Synektik two organised parts of its own Czech business3.
What makes the relationship unusual is that the competitor holds every card. Intuitive's products were 48,4% of the equipment segment's revenue in the year to September 20254, and 80,2% of its purchases5. It does not need to undercut Synektik in a tender; it only needs to let the contract lapse. And it has the money: about $533,1 million for three countries, paid in cash6.
The acquisition also shows what Intuitive values. Of the $561,0 million fair value of the net assets it acquired, $279,8 million was intangible and other assets, $218,0 million goodwill and $60,5 million property, plant and equipment7. It paid for relationships and a position in the market, the same things Synektik has built in its territory.
The rating is for Synektik's position against this rival, and it is thin: strong until 2031, uncertain after. Every point of the equipment segment that Intuitive's products add raises the cost of a non-renewal.
Renewed to 2031 in February 2026.
The exposure if the supplier went direct.
Source: Synektik annual management board report, year to September 2025 ↗- ReportedOn 1 March 2026 it bought the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for about $533,1 million and became the direct distributor for Italy, Spain, Portugal, Malta and San Marino.Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
- ReportedThe annex of February 2026 extended the Polish, Czech, Slovak and Baltic agreement to 31 December 2031 and added Ukraine.Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
- ReportedIn 2022 Intuitive had gone further still, selling Synektik two organised parts of its own Czech business.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedIntuitive's products were 48,4% of the equipment segment's revenue in the year to September 2025, and 80,2% of its purchases.Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedIntuitive's products were 48,4% of the equipment segment's revenue in the year to September 2025, and 80,2% of its purchases.Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedAnd it has the money: about $533,1 million for three countries, paid in cash.Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
- ReportedOf the $561,0 million fair value of the net assets it acquired, $279,8 million was intangible and other assets, $218,0 million goodwill and $60,5 million property, plant and equipment.Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗